Suchergebnisse - "Gemtuzumab"

PubPharm (943)

1

Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia

enthalten in: Leukemia research | 2024

von Bourne, G. | Diebold, K. | Espinoza-Gutarra, M. | +6

2

Therapeutic plasma exchange as an intervention for gemtuzumab ozogamicin impaired hemoglobin scavenging : A case and systematic review

enthalten in: Journal of clinical apheresis | 2024

von Adkins, B. | Noland, D. | Slone, T. | +1

3

Extramedullary infiltration in pediatric acute myeloid leukemia : Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative

enthalten in: Pediatric blood & cancer | 2024

von Li, W. | Shi, M. | Zhou, P. | +6

4

Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML : Results from the SAL-MODULE phase I study

enthalten in: British journal of haematology | 2024

von Röllig, C. | Schliemann, C. | Ruhnke, L. | +17

5

Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Serio, B. | Grimaldi, F. | Ammirati, L. | +11

6

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

enthalten in: Blood cancer journal | 2024

von Tiong, I. | Wall, M. | Bajel, A. | +36

7

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Russell, N. | Wilhelm-Benartzi, C. | Othman, J. | +117

8

Pediatric acute myeloid leukemia - novel approaches

enthalten in: Current opinion in hematology | 2024

von Karol, S. | Gueguen, G.

9

Gemtuzumab Ozogamicin in Acute Myeloid Leukemia : Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review

enthalten in: Biomedicines | 2024

von Collados-Ros, A. | Muro, M. | Legaz, I.

10

Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic Leukemia : A Case Report

enthalten in: Case reports in oncology | 2024

von Imataki, O. | Fujita, H. | Uemura, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[95]